Detalhe da pesquisa
1.
Disease severity-based subgrouping of type 2 diabetes does not parallel differences in quality of life: the Maastricht Study.
Diabetologia
; 67(4): 690-702, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38206363
2.
Illustrating the financial consequences of outcome-based payment models from a payers perspective- the case of autologous gene therapy atidarsagene autotemcel (Libmeldy®).
Value Health
; 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38795960
3.
Regulatory, health technology assessment and company interactions: the current landscape and future ecosystem for drug development, review and reimbursement.
Int J Technol Assess Health Care
; 39(1): e20, 2023 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37039100
4.
Reported Challenges in Health Technology Assessment of Complex Health Technologies.
Value Health
; 25(6): 992-1001, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35667787
5.
Understanding innovation of health technology assessment methods: the IHTAM framework.
Int J Technol Assess Health Care
; 38(1): e16, 2022 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35094736
6.
Addressing uncertainty in relative effectiveness assessments by HTA organizations.
Int J Technol Assess Health Care
; 38(1): e17, 2022 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35094740
7.
Comparative effectiveness and safety of pharmaceuticals assessed in observational studies compared with randomized controlled trials.
BMC Med
; 19(1): 307, 2021 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34865623
8.
Early Cost-Effectiveness of Onasemnogene Abeparvovec-xioi (Zolgensma) and Nusinersen (Spinraza) Treatment for Spinal Muscular Atrophy I in The Netherlands With Relapse Scenarios.
Value Health
; 24(6): 759-769, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34119073
9.
Bridging health technology assessment and healthcare quality improvement using international consortium of health outcomes measurement standard sets.
Int J Technol Assess Health Care
; 38(1): e6, 2021 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36317685
10.
Exploring the opportunities for alignment of regulatory postauthorization requirements and data required for performance-based managed entry agreements.
Int J Technol Assess Health Care
; 37(1): e83, 2021 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34424152
11.
Information Patients With Melanoma Spontaneously Report About Health-Related Quality of Life on Web-Based Forums: Case Study.
J Med Internet Res
; 23(12): e27497, 2021 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34878994
12.
Efficacy gap between phase II and subsequent phase III studies in oncology.
Br J Clin Pharmacol
; 86(7): 1306-1313, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32034790
13.
Differences in Health Technology Assessment Recommendations Among European Jurisdictions: The Role of Practice Variations.
Value Health
; 23(1): 10-16, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31952664
14.
Unmet Medical Need: An Introduction to Definitions and Stakeholder Perceptions.
Value Health
; 22(11): 1275-1282, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31708064
15.
An operationalization framework for lifecycle HTA.
Int J Technol Assess Health Care
; : 1-29, 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38751240
16.
Lifecycle HTA: Promising applications and a framework for implementation.
Int J Technol Assess Health Care
; : 1-25, 2024 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38727087
17.
The impact of quality-of-life data in relative effectiveness assessments of new anti-cancer drugs in European countries.
Qual Life Res
; 26(9): 2479-2488, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28401419
18.
Can a Joint Assessment Provide Relevant Information for National/Local Relative Effectiveness Assessments? An In-Depth Comparison of Pazopanib Assessments.
Value Health
; 18(5): 663-72, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26297095
19.
Standardized reporting for rapid relative effectiveness assessments of pharmaceuticals.
Int J Technol Assess Health Care
; 30(5): 488-96, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25747557
20.
Piloting international production of rapid relative effectiveness assessments of pharmaceuticals.
Int J Technol Assess Health Care
; 30(5): 521-9, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25747562